HRT Financial
MRVI icon

HRT Financial’s Maravai LifeSciences MRVI Stock Holding History

HRT Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.5M Buy
1,371,328
+302,574
+28% +$2.09M 0.02% 818
2026
Q2 		$6.67M Buy
1,068,754
+992,471
+1,301% +$4.28M 0.01% 980
2026
Q1 		$215K Sell
76,283
-291,628
-79% -$989K ﹤0.01% 3153
2025
Q4 		$1.2M Buy
+367,911
New +$1.24M ﹤0.01% 1619
2025
Q2 		– Sell
-33,116
Closed -$73K – 3228
2025
Q1 		$73K Sell
33,116
-120,559
-78% -$476K ﹤0.01% 2199
2024
Q4 		$837K Buy
+153,675
New +$989K ﹤0.01% 1162
2024
Q2 		– Sell
-397,947
Closed -$3.45M – 2769
2024
Q1 		$3.45M Buy
397,947
+285,561
+254% +$1.93M 0.02% 375
2023
Q4 		$736K Buy
+112,386
New +$726K 0.01% 1148
2023
Q3 		– Sell
-96,365
Closed -$1.2M – 2835
2023
Q2 		$1.2M Buy
96,365
+78,619
+443% +$1.06M 0.01% 840
2023
Q1 		$248K Buy
+17,746
New +$255K ﹤0.01% 1827
2022
Q3 		– Sell
-9,176
Closed -$260K – 3248
2022
Q2 		$260K Sell
9,176
-33,371
-78% -$1.06M ﹤0.01% 2113
2022
Q1 		$1.5M Buy
+42,547
New +$1.43M 0.01% 781
2021
Q1 		– Sell
-305,395
Closed -$8.57M – 2981
2020
Q4 		$8.57M Buy
+305,395
New +$8.5M 0.17% 95

Other funds holding MRVI

GTCR LLC
GTCR LLC Chicago, Illinois $4.29B AUM 4.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

HRT Financial's MRVI Position: Q3 2026 in Review

HRT Financial increased its Maravai LifeSciences (MRVI) stake by 28% in Q3 2026, buying an estimated $2.09M and bringing the position to 1,371,328 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #818.

HRT Financial first reported a position in MRVI in Q4 2020 and has held it in 13 quarters since. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • HRT Financial held 1,371,328 shares of Maravai LifeSciences worth $10.5M as of Q3 2026.
  • HRT Financial bought 302,574 Maravai LifeSciences shares in Q3 2026, an estimated $2.09M.
  • Maravai LifeSciences made up 0.02% of HRT Financial's portfolio in Q3 2026, its #818 holding.
  • HRT Financial first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 13 quarters since.
  • 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.